Biotech

All Articles

GSK's long-acting breathing problem medicine cut in half assaults in period 3

.GSK's long-acting bronchial asthma procedure has been actually presented to cut in half the variety...

AstraZeneca, Daiichi unload Dato-DXd's total survival stop working

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has neglected to...

Roivant reveals new 'vant' to progress Bayer hypertension med

.Matt Gline is back with a brand new 'vant' provider, after the Roivant Sciences chief executive off...

Viridian eye health condition period 3 smash hits, evolving push to rival Amgen

.Viridian Therapeutics' phase 3 thyroid eye condition (TED) scientific trial has actually struck its...

Bain unveils $3B fund for life science business

.With a strong track record for identifying diamonds in the rough, Bain Financing Lifespan Sciences ...

Genentech's cancer restructure created 'for medical reasons'

.The recent decision to combine Genentech's two cancer cells teams was actually produced "scientific...

Tern oral GLP-1 presents 5% fat loss at 1 month at best dose

.Terns Pharmaceuticals' decision to lose its own liver health condition ambitions may however repay,...

Merck, Daiichi replay very early excellence in tiny cell bronchi cancer with upgraded ADC records

.Merck &amp Co.'s long-running attempt to land a blow on little cell lung cancer cells (SCLC) has ra...

Boehringer, Bayer advance lung cancer cells medications towards Astra battle

.Some patients along with non-small cell lung cancer (NSCLC) have anomalies in a gene named individu...

MBX goes for $136M IPO to take competitor to Ascendis into phase 3

.MBX has elaborated plannings to absorb over $136 thousand from its own IPO as the biotech hopes to ...